| Shareholder | |||||
|---|---|---|---|---|---|
Arch Venture Partners, L.P. | 13.25% | 3.25M | 0.27% | +488.09K | |
Arch Venture Partners, L.P. | 13.25% | 3.25M | 0.67% | +0 | |
Innovative Cellular Therapeutics Holdings Limited | 11.32% | 2.77M | 3.18% | +874.98K | |
Innovative Cellular Therapeutics Holdings Limited | 11.32% | 2.77M | 0.89% | -82.52K | |
Explore Investments LLC | 6.24% | 1.53M | 1.34% | +488.09K | |
Gates Frontier, LLC | 6.24% | 1.53M | 1.34% | +488.09K | |
Gates Frontier, LLC | 6.24% | 1.53M | 0.31% | +0 | |
Explore Investments LLC | 6.24% | 1.53M | 0.31% | +0 | |
GSK Equity Investments, Limited | 6.17% | 1.51M | 0.31% | +0 | |
GSK Equity Investments, Limited | 6.17% | 1.51M | 0.31% | +0 | |
Antonis Indianos | 5.82% | 1.43M | -- | +1.43M | |
Antonis Indianos | 5.82% | 1.43M | 0.29% | +0 | |
Foresite Capital Management, LLC | 5.21% | 1.28M | 0.80% | +0 | |
Mwg Management Ltd. | 4.11% | 1.01M | 0.63% | +0 | |
Mwg Management Ltd. | 4.11% | 1.01M | 0.21% | +0 | |
Vanguard Capital Management, LLC | 3.59% | 879.87K | 0.14% | +74.79K | |
Vanguard Capital Management, LLC | 3.59% | 879.87K | 0.14% | +74.79K | |
Apoletto Limited | 3.08% | 754.70K | 0.16% | +0 | |
Apoletto Limited | 3.08% | 754.70K | 0.16% | +0 | |
BlackRock, Inc. | 2.96% | 724.34K | 2.13% | +532.52K |
